Assyro AI

FDA Orange Book · active-ingredient family

Amcinonide

Amcinonide is approved as 3 brand and 5 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:CYCLOCORT · NDA 019729

3

Brand (NDA)

5

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · cream, lotion, ointment

ProductApplicantApplicationTEApproved
CYCLOCORTRLDASTELLASNDA 019729Jun 13, 1988
CYCLOCORTRLD×2ASTELLASNDA 018116Approved Prior to Jan 1, 1982
CYCLOCORTRLDASTELLASNDA 018498Approved Prior to Jan 1, 1982

Generic (ANDA) products (5)

ProductApplicantApplicationTEApproved
AMCINONIDEGENUS LIFESCIENCESANDA 076065ABMay 15, 2003
AMCINONIDETARO PHARM INDSANDA 076367Mar 19, 2003
AMCINONIDEGENUSANDA 076096Nov 19, 2002
AMCINONIDESOLUBIOMIXANDA 076329Nov 06, 2002
AMCINONIDETARO PHARM INDSANDA 076229ABMay 31, 2002

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Amcinonide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.